Boehringer Ingelheim Pharmaceuticals Inc. / Lilly USA
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and independently owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units, Human Pharma and Animal Health. Learn more at www.boehringer-ingelheim.com/us.
Brands: Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA welcome you and look forward to the opportunity to share the latest clinical information on our products.